Bittium Oyj (LON:0JG5)

Verve Therapeutics Revenue

In the year 2024, Bittium Oyj had annual revenue of 85.33M EUR with 13.01% growth. Bittium Oyj had revenue of 23.71M in the quarter ending December 31, 2024, with 19.45% growth.

• Revenue: 85.33M EUR
• Revenue Growth: +13.01%
• P/S Ratio: 4.50
• Revenue / Employee: 166.98K EUR
• Employees: 511
• Market Cap: 317.76M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	85.33M	9.82M	13.01%
Dec 31, 2023	75.50M	-7.46M	-8.99%
Dec 31, 2022	82.96M	-4.44M	-5.08%
Dec 31, 2021	87.40M	8.67M	11.01%
Dec 31, 2020	78.73M	3.34M	4.43%